Our data provide two major findings on CTNNB1 syndrome: (1) we elucidate novel molecular and functional changes in the brain that advance our understanding of the pathophysiology of this disorder, and (2) we provide the first evidence for a therapeutic treatment that normalizes phenotypes relevant to this unmet medical need. Here, CTNNB1 is linked to Down syndrome.